Stem Cell-Based Therapeutic Strategies in Diabetic Wound Healing

Impaired wound healing and especially the all-too-common occurrence of associated diabetic foot ulcers (DFU) are becoming an increasingly urgent and deteriorating healthcare issue, which drastically impact the quality of life and further heighten the risks of infection and amputation in patients with diabetes mellitus. Amongst the multifactorial wound healing determinants, glycemic dysregulation has been identified to be the primary casual factor of poor wound healing. Unfortunately, current therapeutic modalities merely serve as moderate symptomatic relieves but often fail to completely restore the wound site to its pre-injury state and prevent further recurrence. Stem cell-based therapeutics have been employed for its promising potential to address the root of the problem as they not only exhibit the capacity for self-renewal and differentiation towards multiple lineages, but also have been disclosed to participate in mediating variant growth factors and cytokines. Herein we review the current literatures on the therapeutic benefits of using various kinds of stem cells, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and adipose-derived stem cells (ASCs) in diabetic wound healing by searching on the PubMed (R) Database for publications. This study shall serve as an overview of the current body of research with particular focus on autologous ASCs and the laboratory expandable iPSCs in hope of shedding more light on this attractive therapy so as to elevate the efficacy of wound healing that is almost always compromised in diabetic patients.

Automated summary

This review summarizes the therapeutic benefits of using various types of stem cells, including embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, and adipose-derived stem cells, in diabetic wound healing. The focus is on autologous adipose-derived stem cells and laboratory expandable induced pluripotent stem cells. The study aims to shed more light on this attractive therapy in order to improve the efficacy of wound healing in diabetic patients.